{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:05:50Z","timestamp":1750309550893,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":19,"publisher":"ACM","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,13]]},"DOI":"10.1145\/3706890.3706932","type":"proceedings-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T13:37:20Z","timestamp":1736775440000},"page":"240-243","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The application of artificial intelligence in cancer diagnosis and treatment in the era of precision medicine"],"prefix":"10.1145","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9950-0162","authenticated-orcid":false,"given":"Jiaqi","family":"Xie","sequence":"first","affiliation":[{"name":"Medical college, YanBian University, Yanji, Jilin, China"}]}],"member":"320","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"e_1_3_3_1_1_2","first-page":"72","volume":"2021","author":"Wentzensen N","unstructured":"Wentzensen N, Lahrmann B, Clarke MA, Kinney W, Tokugawa D, Poitras N, Locke A, Bartels L, Krauthoff A, Walker J, Zuna R, Grewal KK, Goldhoff PE, Kingery JD, Castle PE, Schiffman M, Lorey TS, Grabe N. Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening. J Natl Cancer Inst. 2021 Jan 4;113(1):72-79.","journal-title":"J Natl Cancer Inst."},{"key":"e_1_3_3_1_2_2","doi-asserted-by":"crossref","unstructured":"Kundrod KA Jeronimo J Vetter B Maza M Murenzi G Phoolcharoen N Castle PE. Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing. PLOS Glob Public Health. 2023 Aug 16;3(8):e0001982.","DOI":"10.1371\/journal.pgph.0001982"},{"key":"e_1_3_3_1_3_2","doi-asserted-by":"crossref","unstructured":"Hosny A Parmar C Quackenbush J Schwartz LH Aerts HJWL. Artificial intelligence in radiology. Nat Rev Cancer. 2018 Aug;18(8):500-510.","DOI":"10.1038\/s41568-018-0016-5"},{"key":"e_1_3_3_1_4_2","doi-asserted-by":"crossref","unstructured":"El Nahhas OSM Loeffler CML Carrero ZI van Treeck M Kolbinger FR Hewitt KJ Muti HS Graziani M Zeng Q Calderaro J Ortiz-Br\u00fcchle N Yuan T Hoffmeister M Brenner H Brobeil A Reis-Filho JS Kather JN. Regression-based Deep-Learning predicts molecular biomarkers from pathology slides. Nat Commun. 2024 Feb 10;15(1):1253.","DOI":"10.1038\/s41467-024-45589-1"},{"key":"e_1_3_3_1_5_2","doi-asserted-by":"crossref","unstructured":"Wainberg M Merico D Delong A Frey BJ. Deep learning in biomedicine. Nat Biotechnol. 2018 Oct;36(9):829-838.","DOI":"10.1038\/nbt.4233"},{"key":"e_1_3_3_1_6_2","doi-asserted-by":"crossref","unstructured":"Esteva A Kuprel B Novoa RA Ko J Swetter SM Blau HM Thrun S. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017 Feb 2;542(7639):115-118.","DOI":"10.1038\/nature21056"},{"key":"e_1_3_3_1_7_2","doi-asserted-by":"crossref","unstructured":"Echle A Rindtorff NT Brinker TJ Luedde T Pearson AT Kather JN. Deep learning in cancer pathology: a new generation of clinical biomarkers. Br J Cancer. 2021 Feb;124(4):686-696.","DOI":"10.1038\/s41416-020-01122-x"},{"key":"e_1_3_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Mouliere F Chandrananda D Piskorz AM Moore EK Morris J Ahlborn LB Mair R Goranova T Marass F Heider K Wan JCM Supernat A Hudecova I Gounaris I Ros S Jimenez-Linan M Garcia-Corbacho J Patel K \u00d8strup O Murphy S Eldridge MD Gale D Stewart GD Burge J Cooper WN van der Heijden MS Massie CE Watts C Corrie P Pacey S Brindle KM Baird RD Mau-S\u00f8rensen M Parkinson CA Smith CG Brenton JD Rosenfeld N. Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med. 2018 Nov 7;10(466):eaat4921.","DOI":"10.1126\/scitranslmed.aat4921"},{"key":"e_1_3_3_1_9_2","doi-asserted-by":"crossref","unstructured":"Moss EL Gorsia DN Collins A Sandhu P Foreman N Gore A Wood J Kent C Silcock L Guttery DS. Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression. Cancers (Basel). 2020 Aug 10;12(8):2231.","DOI":"10.3390\/cancers12082231"},{"key":"e_1_3_3_1_10_2","doi-asserted-by":"crossref","unstructured":"Mouliere F Chandrananda D Piskorz AM Moore EK Morris J Ahlborn LB Mair R Goranova T Marass F Heider K Wan JCM Supernat A Hudecova I Gounaris I Ros S Jimenez-Linan M Garcia-Corbacho J Patel K \u00d8strup O Murphy S Eldridge MD Gale D Stewart GD Burge J Cooper WN van der Heijden MS Massie CE Watts C Corrie P Pacey S Brindle KM Baird RD Mau-S\u00f8rensen M Parkinson CA Smith CG Brenton JD Rosenfeld N. Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med. 2018 Nov 7;10(466):eaat4921.","DOI":"10.1126\/scitranslmed.aat4921"},{"key":"e_1_3_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Jiang YZ Liu Y Xiao Y Hu X Jiang L Zuo WJ Ma D Ding J Zhu X Zou J Verschraegen C Stover DG Kaklamani V Wang ZH Shao ZM. Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial. Cell Res. 2021 Feb.","DOI":"10.1038\/s41422-020-0375-9"},{"key":"e_1_3_3_1_12_2","doi-asserted-by":"crossref","unstructured":"Vasanthakumari P Zhu Y Brettin T Partin A Shukla M Xia F Narykov O Weil MR Stevens RL. A Comprehensive Investigation of Active Learning Strategies for Conducting Anti-Cancer Drug Screening. Cancers (Basel). 2024 Jan 26;16(3):530.","DOI":"10.3390\/cancers16030530"},{"key":"e_1_3_3_1_13_2","doi-asserted-by":"crossref","unstructured":"Trivizakis E Papadakis GZ Souglakos I Papanikolaou N Koumakis L Spandidos DA Tsatsakis A Karantanas AH Marias K. Artificial intelligence radiogenomics for advancing precision and effectiveness in oncologic care (Review). Int J Oncol. 2020 Jul;57(1):43-53.","DOI":"10.3892\/ijo.2020.5063"},{"key":"e_1_3_3_1_14_2","doi-asserted-by":"crossref","unstructured":"Poudel P Nyamundanda G Patil Y Cheang MCU Sadanandam A. Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses. NPJ Breast Cancer. 2019 Aug 2;5:21.","DOI":"10.1038\/s41523-019-0116-8"},{"key":"e_1_3_3_1_15_2","doi-asserted-by":"crossref","unstructured":"Suwannasom N Sriaksorn N Thepmalee C Thephinlap C Tanamatayarat P Khoothiam K B\u00e4uemler H Na-Ek N. Efficacy and safety of nanoparticle albumin-bound paclitaxel in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials and observational studies. Heliyon. 2023 Nov 1;9(11):e21903.","DOI":"10.1016\/j.heliyon.2023.e21903"},{"key":"e_1_3_3_1_16_2","doi-asserted-by":"crossref","unstructured":"Gerwing M Herrmann K Helfen A Schliemann C Berdel WE Eisenbl\u00e4tter M Wildgruber M. The beginning of the end for conventional RECIST - novel therapies require novel imaging approaches. Nat Rev Clin Oncol. 2019 Jul;16(7):442-458.","DOI":"10.1038\/s41571-019-0169-5"},{"key":"e_1_3_3_1_17_2","doi-asserted-by":"crossref","unstructured":"Arbour KC Luu AT Luo J Rizvi H Plodkowski AJ Sakhi M Huang KB Digumarthy SR Ginsberg MS Girshman J Kris MG Riely GJ Yala A Gainor JF Barzilay R Hellmann MD. Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade. Cancer Discov. 2021 Jan;11(1):59-67.","DOI":"10.1158\/2159-8290.CD-20-0419"},{"key":"e_1_3_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32998-8"},{"key":"e_1_3_3_1_19_2","doi-asserted-by":"crossref","unstructured":"Arbour KC Luu AT Luo J Rizvi H Plodkowski AJ Sakhi M Huang KB Digumarthy SR Ginsberg MS Girshman J Kris MG Riely GJ Yala A Gainor JF Barzilay R Hellmann MD. Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade. Cancer Discov. 2021 Jan;11(1):59-67.","DOI":"10.1158\/2159-8290.CD-20-0419"}],"event":{"name":"ISAIMS 2024: 2024 5th International Symposium on Artificial Intelligence for Medicine Science","acronym":"ISAIMS 2024","location":"Amsterdam Netherlands"},"container-title":["Proceedings of the 2024 5th International Symposium on Artificial Intelligence for Medicine Science"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3706890.3706932","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3706890.3706932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T01:18:46Z","timestamp":1750295926000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3706890.3706932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":19,"alternative-id":["10.1145\/3706890.3706932","10.1145\/3706890"],"URL":"https:\/\/doi.org\/10.1145\/3706890.3706932","relation":{},"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"2025-01-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}